Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00374647 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
A Phase 4 study, sponsored by University of Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 17
- Enrollment target
NCT00374647 is a Phase 4 study that has completed, run by University of Cincinnati. The registered enrollment target is 17 participants.
The verdict
NCT00374647, a Phase 4 study, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 17 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of early corticosteroid withdrawal and simultaneous calcineurin inhibitor withdrawal in recipients of primary renal allografts maintained long-term on MMF and sirolimus.
Interventions
- DRUG sirolimus
- DRUG mycophenolate mofetil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2005-03 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00374647
The ClinicalTrials.gov registry entry for NCT00374647 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sirolimus is the first listed.
NCT00374647 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00374647 about?
NCT00374647 is a clinical study titled "Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts". Evaluate the safety and efficacy of early corticosteroid withdrawal and simultaneous calcineurin inhibitor withdrawal in recipients of primary renal allografts maintained long-term on MMF and sirolimus.
What is the current status of trial NCT00374647?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 17 participants. The study started on 2005-03. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00374647?
The interventions under investigation include: sirolimus (DRUG), mycophenolate mofetil (DRUG).
Who is sponsoring clinical trial NCT00374647?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.